On Wednesday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: MasTec, (NYSE:MTZ), BioMarin Pharmaceutical (NASDAQ:BMRN), Express Scripts Holding Company (NASDAQ:ESRX), World Wrestling Entertainment, (NYSE:WWE)
On March 31, 2015 MasTec, Inc. (NYSE:MTZ) uncovered that it has received a consent from the bank group under its senior secured credit facility (the “Bank Group”) to delay delivery of its annual audited financial statements for the fiscal year ended December 31, 2014 and its quarterly financial statements for the fiscal quarter ending March 31, 2015. Under the terms of the consent, the Bank Group has extended the deadline for such delivery requirements to June 1, 2015.
MasTec, Inc. (NYSE:MTZ) fell -2.95%, and closed at $18.73. The stock has the beta value of 1.31, and its volatility for the week is 4.69%, while for the month it is 4.74%. The company has the market capitalization of $1.58 billion. The company holds the book value per share of 13.74, whereas cash per share is 0.09. Price to book ratio remained 1.36, while price to sale ratio is 0.34. Analysts mean recommendation for the stock is said to be 1.70 (where 1=Buy, 5=sale).
MasTec, Inc. (MTZ) an infrastructure construction company, offers engineering, building, installation, maintenance, and upgrade services for energy, utility, and communications infrastructure primarily in the United States. It operates in five segments: Communications, Oil and Gas, Electrical Transmission, Power Generation and Industrial, and Other.
Formerly On March 30, 2015 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) disclosed the results of a post-hoc sub-analysis of the PKU-016 or ASCEND study, the largest randomized controlled trial evaluating neurocognitive outcomes in patients with phenylketonuria (PKU) treated with the approved therapy Kuvan(R) (sapropterin dihydrochloride)at the 2015 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting. The sub-analysis included 86 subjects 8 to 17 years of age with PKU who were randomized to blinded treatment with Kuvan (N = 43) or placebo (N = 43) for 13 weeks, after which all individuals received open label Kuvan for an additional 13 weeks.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) decreased -2.94%, and closed at $120.95,. The company holds the market capitalization of $19.83 billion. For the last twelve months, the stock was able to keep return on equity at -9.00%, while return on assets at -5.60%, in response to its return on investment at -4.70%. Its 20-day moving average gained 0.47%, below 50-day moving average of 11.66%, below 200-day moving average of 45.02% from the latest market price of $120.95. The mean recommendation of analysts for this stock is 1.80. (Where 1=Buy, 5=Sale).
BioMarin Pharmaceutical Inc. (BMRN) develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and globally.
Express Scripts Holding Company (NASDAQ:ESRX) declined -2.93%, and closed at $84.23. The company has the market capitalization of $63.24 billion. The beta value of the stock is 1.17. On the other hand the stock’s volatility for the week is 2.86%, and for the month is 1.96%. The stock’s price to book ratio is $3.07, however price to sale ratio is $0.61. Analyst’s mean recommendation regarding this stock is 2.20. (Where 1=Buy, 5=Sale).
Express Scripts Holding Company (ESRX) works as a pharmacy benefit management (PBM) company in the United States and Canada. The company works through two segments, PBM and Other Business Operations.
World Wrestling Entertainment, Inc. (NYSE:WWE) uncovered that WrestleMania 31 broke records for viewership, attendance, social and digital media engagement and merchandise sales.
WWE’s pop-culture extravaganza was watched by more than 1.3 million global households on WWE Network alone.
Most-watched WrestleMania in history, with pay-per-view data still forthcoming.
The night after WrestleMania 31, Monday Night Raw® was the most-watched episode in nearly three years delivering 5.4 million viewers.
Raw’s top telecast since WWE celebrated Raw 1000 on July 23, 2012.
Raw was Monday night’s most-watched program on all of cable television for the 11th week in a row.
World Wrestling Entertainment, Inc. (NYSE:WWE)’s shares picked down -2.93%, and closed at $13.60. The stock volatility for the week is 9.00%, while for the month remained 4.88%. The company holds consensus target price of $18.48.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.40 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 175.00% and Annual EPS growth for the past 5 years is considered as -20.90%.
The mean recommendation of analysts for this stock is 2.40. (Where 1=Buy, 5=Sale).
World Wrestling Entertainment, Inc. (WWE) an integrated media and entertainment company, involves in the sports entertainment business in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
